FDA Investigator Patricia Fhughes Troost

Patricia Fhughes Troost has inspections in 9 countries as of 27 Jul 2023. Patricia Fhughes Troost has collaborated with a combinined 5020 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
25
Last Inspection Date:
27 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Netherlands, Korea (Republic of), France, Switzerland, Japan, Germany, Belgium, Israel
Co-Investigator(s):
Abdur Razzaque, Adaliz Santaliz Cruz, Adetutu M Gidado, Aditi S Thakur, Aimee Cunningham, PhD, Alan A Rivera, Alberto A Viciedo, Anastasia G Lolas, Anastasia M Shields, Andrea George, PhD, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Anne E Johnson, Arlene M Badillo, Arsen Karapetyan, Arthur S Williams, Jr, Ashar P Parikh, Ashley N Queen, PhD, Bo Chi, PhD, Brandon C Heitmeier, Brenda W Uratani, PhD, Brooke K Higgins, Bruce G Cooper, Burnell M Henry, Calvin B Koerner, Candace Gomez Broughton, PhD, Candace Y Gomez Broughton, Carl A Anderson, Carla J Lundi, Charles I Ann, Charles M Edwards, Charles Yuanchia Kuo, PhD, Cheryl A Clausen, Chiang Syin, PhD, Chikako Torigoe, PhD, Christian D Lynch (CDL), Christopher Downey, PhD, Colleen Thomas, PhD, Concepcion Cruz, Jr, Cynthia Jim, CSO, Daryl A Dewoskin, David M Beltran, Dawn L Wydner, Deborah J Parris, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Donald C Obenhuber, PhD, Dov Pluznik, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Eliezar Ramos, Ellen P Madigan, Emest F Bizjak, Erik W Koester, Erika V Butler, Gayle S Lawson, George Pyramides, Gerald B Seaborn, Jr, Gilbert T Salud, Ginger M Sykes, Gloria E Parra, Graeme E Price, Guerlain Ulysse, Gwyn G Dickinson, Hala L Selby, Haoheng Yan, PhD, Harry J Brewer, Heika R Tait, Helen B Ricalde, Ivis Lnegron Torres, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James L Dunnie, Jr, Jeffrey M Watson, Jennifer Lalama, Jerri Baker, Joao Pedras Vasconcelos, PhD,, John A Podsadowski, John P Mistler, John S Hartford, Jonathan W Chapman, Jorge L Lajara, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose O Hernandez, Jose Ohernandez Guzman, Jose R Lopez, Jose Velez, Juan A Morales, Julianne C Mccullough, Julie D Bringger, Jun Park, PhD, Junho Pak, Justin A Boyd, Justine Tomasso, Kalavati Suvarna, PhD, Katherine E Jacobitz, Kathleen M Jordan, Kathryn A Nagy, Kelvin Cheung, Kendra L Brooks, Kent C Faul, Kevin D Kallander, Kim Lthomas Cruse, Ko U Min, Kristin M Abaonza, Kristina J Donohue, Kurt A Brorson, PhD, L Norwood, Lakshmi Narasimhan, PhD, Lance M De Souza, MBA, Larry K Austin, Lauren N Barber, Laurie Graham, Laurie Nelson, Lawrence W Farina, LCDR Chad N Thompson, LCDR Debra Emerson, Leiyun Boone, PhD, Leonard H Lavi, Libia M Lugo, Linda M Sacco, Lori A Holmquist, Lori J Silverstein, LT Rafael Gonzalez, M Pedgen, Madushini Dharmasena, PhD, Marcus F Yambot, Maria Estrella, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marie F Morin, Marion Michaelis, Mariza M Jafary, Marlene G Swider, Mary E Farbman, PhD, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew B Casale, Maxwell Van Tassell, PhD, Megan A Haggerty, Melissa D Ray, Michael A Charles, Michael E Maselli, Michael J Verdi, Michael Levin, Michael R Klapal, Michael Shanks, MS, Michele L Forster, PhD, Michele Perry Williams, Michelle M Noe, Michelle Y Clark Stuart, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Minh D Phan, Monica Commerford, PhD, Monique Rac Lester, Mra Davism, Myriam M Sosa, Nailing Zhang, Nancy G Schmidt, Nancy T Waites, Nebil A Oumer, Nicholas C Mendiola, Nicholas Obiri, PhD, Nicole K Trudel, Niketa Patel, Nikolay Spiridonov, Nirjal Bhattarai, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Obinna R Echeozo, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patrick L Wisor, Paul E Stein, Paul L Bellamy, Paul Z Balcer, Paula A Trost, Pete Amin (Pankaj), Peter Adams, PhD, Peter R Lenahan, Prabhu P Raju, Qing Joanna Zhou, PhD, Ralph Jerndal, Ramesh Potla, PhD, Ramon A Hernandez, Ramon E Martinez, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard K Vogel, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert C Coleman, Robert Darius, Robert J Ham, Robert J Martin, Robert M Barbosa, Rodney D Combs, Roger F Zabinski, Rose M Ashley, Russ E Davis, Russell J Glapion, Saleem A Akhtar, Samina S Khan, Samuel K Gibbons, Jr, Samuel Mindaye, Sangeeta M Khurana, PhD, Sarah Johnson, PhD, Scott R Nichols, PhD, Sean R Bryd, Sean R Marcsisin, Seneca D Toms, Sharon K Thoma, PharmD, Sidney B Pricsmeyer, Sidney B Priesmeyer, Stacey S Degarmo, Stacie A Woods, Stephen C Smith, Stephen D Brown, Steven C Madzo, Steven E Kane, Steven Fong, MS, PhD, Steven M Weinman, Stuart W Russell, Susan F Laska, MS, Susan M Jackson, Tamil Arasu, PhD, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy T Kapsala, Timothy Wadkin, PhD, Tina M Pawlowski, Torrance J Slayton, Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Viviana Matta, Viviana R Ramirez, Vlada Matusovsky, Wayne E Seifert, Wendy G Tan, PhD, William M Rennells, Xianghong Jing (Emily), PhD, Xiaoping Guan, Yan Wang, Yanming An, PhD, Yasamin Ameri, Yehualashet A Gessesse, Yvesna C Blaise, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhongren Wu

Patricia Fhughes Troost's Documents

Publish Date Document Type Title
July, 2022 EIR Revance Therapeutics, Inc. - EIR, 2022-07-15
October, 2007 EIR CELLTRION Inc - EIR, 2010-11-10
July, 2022 FDA 483 Revance Therapeutics, Inc. - Form 483, 2022-07-15
February, 2013 EIR Bristol-Myers Squibb Co., Inc. - EIR, 2013-02-08
February, 2013 FDA 483 Bristol-Myers Squibb Co., Inc. - Form 483, 2013-02-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more